Post-traumatic Stress Disorder Treatment Market Size

  • Report ID: 6496
  • Published Date: Oct 01, 2024
  • Report Format: PDF, PPT

Post-traumatic Stress Disorder Treatment Market Size

Post-traumatic Stress Disorder Treatment Market size is estimated at USD 17.7 billion in 2024 and is predicted to reach USD 35.1 billion by the end of 2037, expanding at a CAGR of 5.4% during the forecast period, i.e., 2025-2037. In 2025, the industry size of PTSD treatment is assessed at USD 18.6 billion.

The PTSD treatment market is expanding mainly due to the growing advancements in therapies and the increasing prevalence of the condition. In 2024, the World Health Organization (WHO) stated that PTSD is projected to have affected 3.9% of people worldwide at some point in their lives. There is a rising prevalence of PTSD due to factors such as rising global conflicts, natural disasters, and the growing awareness of mental health issues.

Growing advancements in therapeutic options, including pharmacological treatments and evidence-based therapies such as cognitive behavioral therapy (CBT) and eye movement desensitization and reprocessing (EMDR), are also contributing to post-traumatic stress disorder (PTSD) treatment market growth. Additionally, increased investment in mental health initiatives and destigmatization of mental health care further enhance treatment accessibility and demand. For instance, the WHO's Special Initiative for Mental Health, neurological, and substance use conditions aims to address and move people with these illnesses toward universal health care. The initiative covers nine countries across six regions: Argentina, Bangladesh, Ghana, Jordan, Nepal, Paraguay, the Philippines, Ukraine, and Zimbabwe.

As of 2023, more than 52 million people had access to newly available local services. This massive expansion was achieved with modest financial investments; the total expenditures for the initiative so far are accounted to be USD 25 million. Thus, for every USD 1 million spent, more than two million people gain access to newly available mental health services in their areas.


Post-traumatic Stress Disorder Treatment Market overview
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 6496
  • Published Date: Oct 01, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of PTSD treatment was over USD 17.7 billion.

The market size for post-traumatic stress disorder (PTSD) treatment is projected to cross USD 35.1 billion by the end of 2037 expanding at a CAGR of 5.4% during the forecast period i.e., between 2025-2037.

The major players in the market are Jazz Pharmaceuticals plc, Bionomics Limited, Merck KGaA, Pfizer Inc., Aurobindo Pharma Limited, GlaxoSmithKline plc (GSK plc), Viatris Inc., Jubilant Pharmova Ltd., H. Lundbeck A/S, Camber Pharmaceuticals, Inc., and others.

The adult segment is anticipated to garner a share/size of 84.7% % during 2025-2037.

The North America post-traumatic stress disorder (PTSD) treatment sector is poised to hold a 40.7% share by the end of 2037.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample